MedPath

TElemedicine to Replace Face-to-face Physician Consultation in Patients With HyperTension : a Pilot Randomized-controlled Trial

Not Applicable
Completed
Conditions
Hypertension
Registration Number
NCT04542564
Lead Sponsor
Chinese University of Hong Kong
Brief Summary

The investigators has developed a blood pressure telemonitoring system. It is hypothesized that, when optimal control of BP is confirmed on the telemonitoring system, the index physician's consultation can be safely deferred, and medications can still be prescribed without such face-to-face consultation. Despite potentially resource-saving for doctors and time-saving for patients, the feasibility and patients' acceptability of the use of the telemonitoring system to replace face-to-face physician consultation remains unclear.

For primary outcome, the investigators hypothesize that this telemonitoring system will be feasible and acceptable to patients and can replace physicians' face-to-face consultations. For secondary outcomes, the investigators hypothesize that patients receiving care through telemonitoring have non-inferior BP control when compared with patients receiving usual care. Furthermore, the patients receiving telemonitoring may also have enhanced self-efficacy and compliance to drugs and lifestyle interventions

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • have a diagnosis of essential hypertension (HT) and are currently taking antihypertensive agents
  • have good control of clinic BP as confirmed on ambulatory blood pressure monitoring (ABPM) (daytime BP ≤135/85mmHg)
  • can read basic Chinese (as the content of the app in Chinese)
  • have a home BP monitor (HBPM)
  • used any mobile app (not HT-related) in the previous 1 year
Exclusion Criteria
  • an inability to give informed consent
  • unwillingness to conduct HBPM or repeated ABPM
  • current use of any other HT app for BP monitoring
  • relative contraindications to ABPM (diagnosed atrial fibrillation, occupational drivers or patients with bleeding tendencies)
  • severe mental illness, including those diagnosed with schizophrenia, dementia or as being actively suicidal, because these patients may have diminished ability to use the HT app;
  • a diagnosis of other chronic disease(s) that need regular physical assessments and doctors' consultations (e.g. diabetes and asthma that are being treated, but patients with hypertension and hyperlipidaemia will remain eligible)
  • diagnosed active cancer,

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
rate of retentionbaseline, 6-month

number of dropouts during the 6-month study period

rate of recruitmentbaseline

number of patients recruited per month during the recruitment period

acceptabilityat 6-month

interview of around 20 patients in the intervention group

Secondary Outcome Measures
NameTimeMethod
blood pressure levels on 24-hour ambulatory blood pressurebaseline, 6-month

daytime, nighttime, and 24-hour systolic and diastolic blood pressure

eHealth literacybaseline, 6-month

Chinese 8-item eHealth literacy scale; higher scores represented higher eHealth literacy

healthcare utilization6-month

number of visits to general outpatient clinic, specialist clinic(s) and hospitalization during study period

health literacybaseline, 6-month

3-item Brief Health Literacy; higher scores represented higher health literacy

medication and diet adherencebaseline, 6-month

Treatment Adherence Questionnaire for Patients with Hypertension (TAQPH); Score was summed to give a total range, higher score represented better adherence

exercise levelbaseline, 6-month

Godin-Shephard Leisure-Time Physical Activity Questionnaire (GSLTPAQ); higher scores represented higher exercise level

self-efficacy scalebaseline, 6-month

5-item self-efficacy scale specific to hypertension; a mean score from the items of a 9 or above were classified as having good self-efficacy

Trial Locations

Locations (1)

Lek Yuen Clinic and Fanling clinic

🇭🇰

Hong Kong, Hong Kong

Lek Yuen Clinic and Fanling clinic
🇭🇰Hong Kong, Hong Kong

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.